Business · 16/10/2009Updated: 10/17/2026 · 1 min read
FDA Postpones National Mammography Quality Assurance Advisory Committee Meeting
Summary
The Food and Drug Administration (FDA) has postponed the November 2, 2009, meeting of the National Mammography Quality Assurance Advisory Committee due to unavailability of guidance documents, originally scheduled for discussion.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →